PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Zach, N.* ; Ennist, D.L.* ; Taylor, A.A.* ; Alon, H.* ; Sherman, A.V.* ; Küffner, R. ; Walker, J.* ; Sinani, E.* ; Katsovskiy, I.* ; Cudkowicz, M.E.* ; Leitner, M.L.*

Being PRO-ACTive: What can a clinical trial database reveal about ALS?

Neurotherapeutics 12, 417-423 (2015)
Verlagsversion DOI
Open Access Gold
Advancing research and clinical care, and conducting successful and cost-effective clinical trials requires characterizing a given patient population. To gather a sufficiently large cohort of patients in rare diseases such as amyotrophic lateral sclerosis (ALS), we developed the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) platform. The PRO-ACT database currently consists of >8600 ALS patient records from 17 completed clinical trials, and more trials are being incorporated. The database was launched in an open-access mode in December 2012; since then, >400 researchers from >40 countries have requested the data. This review gives an overview on the research enabled by this resource, through several examples of research already carried out with the goal of improving patient care and understanding the disease. These examples include predicting ALS progression, the simulation of future ALS clinical trials, the verification of previously proposed predictive features, the discovery of novel predictors of ALS progression and survival, the newly identified stratification of patients based on their disease progression profiles, and the development of tools for better clinical trial recruitment and monitoring. Results from these approaches clearly demonstrate the value of large datasets for developing a better understanding of ALS natural history, prognostic factors, patient stratification, and more. The increasing use by the community suggests that further analyses of the PRO-ACT database will continue to reveal more information about this disease that has for so long defied our understanding.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.054
1.586
30
34
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Amyotrophic Lateral Sclerosis ; Clinical Trial Database ; Clinical Trial Simulation ; Disease Progression ; Patient Stratification; Amyotrophic-lateral-sclerosis; Placebo-controlled Trial; Functional Rating-scale; Uric-acid Levels; Disease Progression; Prognostic-factors; Outcome Measures; Survival; Population; Predictors
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 1933-7213
e-ISSN 1878-7479
Zeitschrift Neurotherapeutics
Quellenangaben Band: 12, Heft: 2, Seiten: 417-423 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Bioinformatics and Systems Biology (IBIS)
POF Topic(s) 30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503700-001
DOI 10.1007/s13311-015-0336-z
WOS ID WOS:000353223000013
Scopus ID 84939955331
Scopus ID 84921868033
Erfassungsdatum 2015-02-06
[➜Korrektur melden]